TRPV1+ neurons promote cutaneous immunity against Schistosoma mansoni
The Journal of Immunology · 01.10.2025 · 214 (10) · 2700-2714
DOI: 10.1093/jimmun/vkaf141 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 07.08.2025. Verfasst von Juan M Inclan-Rico und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, United States. Hauptthemen laut MEDLINE: TRPV Cation Channels, Schistosoma mansoni, Schistosomiasis mansoni, Skin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Life Sciences Research Foundation, NIAID NIH HHS, NIH.
Abstract (Originalsprache)
Immunity against skin-invasive pathogens requires mechanisms that rapidly detect, repel, or immobilize the infectious agent. While bacteria often cause painful cutaneous reactions, host skin invasion by the human parasitic helminth Schistosoma mansoni often goes unnoticed. This study interrogated whether pain-sensing skin afferents marked by expression of the ion channel Transient Receptor Potential Vanilloid 1 (TRPV1) contributed to the detection and initiation of skin immunity against S. mansoni. Data show that percutaneous S. mansoni infection significantly reduced thermal pain sensitivity evoked by TRPV1+ neurons. Consistently, isolated skin sensory neurons from infected mice had significantly reduced calcium influx and neuropeptide release in response to the TRPV1 agonist capsaicin compared to neurons from naïve controls. Using gain- and loss-of-function approaches to test whether TRPV1+ neurons initiate host-protective responses revealed that TRPV1+ neurons limit S. mansoni skin entry and migration into the pulmonary tract. Moreover, TRPV1+ neurons were both necessary and sufficient to promote proliferation and cytokine production from dermal γδ T cells and CD4+ T helper cells, as well as to enhance neutrophil and monocyte recruitment to the skin. Taken together, this work suggests that S. mansoni may have evolved to manipulate TRPV1+ neuron activation as a countermeasure to limit IL-17-mediated inflammation, facilitating systemic dissemination and chronic parasitism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, United States.
- Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
- Department of Microbiology and Immunology, School of Medicine, Tulane University, New Orleans, LA, United States.
- Institute for Regenerative Medicine, School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
ORCID-Profile: Juan M Inclan-Rico, Christopher F Pastore
Förderung
- Life Sciences Research Foundation
- NIAID NIH HHS
- NIH
- University of Pennsylvania
- NIH HHS
- NIAID
- Feasibility Grant of the University of Pennsylvania
- NIAMS NIH HHS
Zitieren
APA
Inclan-Rico, J. M., Stephenson, A., Napuri, C. M., Rossi, H. L., Hung, L. Y., Pastore, C. F., Luo, W., & Herbert, D. R. (2025). TRPV1+ neurons promote cutaneous immunity against Schistosoma mansoni. The Journal of Immunology, 214(10), 2700-2714. https://doi.org/10.1093/jimmun/vkaf141
Vancouver
Inclan-Rico JM, Stephenson A, Napuri CM, Rossi HL, Hung LY, Pastore CF, et al. TRPV1+ neurons promote cutaneous immunity against Schistosoma mansoni. The Journal of Immunology. 2025;214(10):2700-2714. doi:10.1093/jimmun/vkaf141
BibTeX
@article{InclanRico2025,
author = {Inclan-Rico, Juan M and Stephenson, Adriana and Napuri, Camila M and Rossi, Heather L and Hung, Li-Yin and Pastore, Christopher F and Luo, Wenqin and Herbert, De'Broski R},
title = {TRPV1+ neurons promote cutaneous immunity against Schistosoma mansoni},
journal = {The Journal of Immunology},
year = {2025},
volume = {214},
number = {10},
pages = {2700--2714},
doi = {10.1093/jimmun/vkaf141}
}
EUVIMED